Tsekovska, R.; Gatev, E.; Mironova, R.; Kerezieva, S.; Ilieva, S.; Ilieva, T.; Vasileva, B.; Niwa, T.; Popova, D.; Vasilev, V.
Serum Levels of Nε-(Carboxymethyl)-Lysine in Chronic Kidney Disease and Type 2 Diabetes Mellitus. Biomedicines 2025, 13, 1672.
https://doi.org/10.3390/biomedicines13071672
AMA Style
Tsekovska R, Gatev E, Mironova R, Kerezieva S, Ilieva S, Ilieva T, Vasileva B, Niwa T, Popova D, Vasilev V.
Serum Levels of Nε-(Carboxymethyl)-Lysine in Chronic Kidney Disease and Type 2 Diabetes Mellitus. Biomedicines. 2025; 13(7):1672.
https://doi.org/10.3390/biomedicines13071672
Chicago/Turabian Style
Tsekovska, Rositsa, Evan Gatev, Roumyana Mironova, Simona Kerezieva, Siyana Ilieva, Teodora Ilieva, Bilyana Vasileva, Toshimitsu Niwa, Daniela Popova, and Vasil Vasilev.
2025. "Serum Levels of Nε-(Carboxymethyl)-Lysine in Chronic Kidney Disease and Type 2 Diabetes Mellitus" Biomedicines 13, no. 7: 1672.
https://doi.org/10.3390/biomedicines13071672
APA Style
Tsekovska, R., Gatev, E., Mironova, R., Kerezieva, S., Ilieva, S., Ilieva, T., Vasileva, B., Niwa, T., Popova, D., & Vasilev, V.
(2025). Serum Levels of Nε-(Carboxymethyl)-Lysine in Chronic Kidney Disease and Type 2 Diabetes Mellitus. Biomedicines, 13(7), 1672.
https://doi.org/10.3390/biomedicines13071672